Patents by Inventor Jun Pan

Jun Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200172545
    Abstract: Disclosed are compounds of Formula (I): or a pharmaceutically acceptable salt thereof. Also provided are methods of using the compounds of Formula (I) for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.
    Type: Application
    Filed: October 3, 2019
    Publication date: June 4, 2020
    Inventors: Oleg Vechorkin, Kai Liu, Jun Pan, Alexander Sokolsky, Hai Fen Ye, Qinda Ye, Wenqing Yao, Joshua Hummel
  • Publication number: 20200155527
    Abstract: The present disclosure describes thiazole and pyridine carboxamide derivatives, their compositions and methods of use. The compounds inhibit the activity of the Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.
    Type: Application
    Filed: November 15, 2019
    Publication date: May 21, 2020
    Inventors: Chu-Biao Xue, Yun-Long Li, Hao Feng, Jun Pan, Anlai Wang, Ke Zhang, Wenqing Yao, Fenglei Zhang, Jincong Zhuo
  • Patent number: 10599596
    Abstract: In an embodiment, a processor for performance state adjustment includes a plurality of processing engines (PEs), a power control unit, and an input/output memory management unit (IOMMU). The IOMMU is to determine a destination PE for a user interrupt based on mapping data of the IOMMU, and to send a notification of the user interrupt to the power control unit. The notification indicates the destination PE for the user interrupt. The power control unit is to adjust a performance state of the destination PE in response to the notification of the user interrupt. Other embodiments are described and claimed.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: March 24, 2020
    Assignee: Intel Corporation
    Inventors: Jacob Jun Pan, Ashok Raj, Srinivas Pandruvada
  • Publication number: 20200087301
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.
    Type: Application
    Filed: August 20, 2019
    Publication date: March 19, 2020
    Inventors: Oleg Vechorkin, Jun Pan, Kai Liu, Alexander Sokolsky, Anlai Wang, Hai Fen Ye, Qinda Ye, Wenqing Yao
  • Publication number: 20200072924
    Abstract: The invention concerns to a gradient coil assembly (62) for use in a Magnetic Resonance Imaging (MRI) system. The gradient coil assembly (62) comprises primary coils (68), shield coils (72) and a supporting structure (10) being arranged between the primary coils (68) and the shield coils (72), wherein the supporting structure (10) comprises at least a supporting element (12) comprising a first end face (14) and at least a first recess (24) with an opening (26) in the first end face (14), wherein the first recess (24) extends in a longitudinal direction (18) of the supporting element (12) forming a tray for receiving a passive shim bar.
    Type: Application
    Filed: December 13, 2017
    Publication date: March 5, 2020
    Inventors: JUN PAN, JIAN LIN, XIANRUI HUANG, CORNELIS LEONARDUS GERARDUS HAM, YAN ZHAO, YUN ZHOU
  • Publication number: 20200057127
    Abstract: The invention relates to cooling a gradient coil (3) of a magnetic resonance imaging system (11). It is an object of the invention to provide an improved assembly of a magnetic resonance imaging apparatus with a gradient coil (3) which allows a cooling of the gradient coil (3) in such a way that a better homogeneity of the temperature distribution an reduced hot spots effects can be achieved.
    Type: Application
    Filed: February 21, 2018
    Publication date: February 20, 2020
    Inventors: JUN PAN, LINGCHENG YUAN, JIAN LIN, YUN ZHOU
  • Publication number: 20200057786
    Abstract: A method and apparatus for providing recommended contents. The method comprises: A search query being received; an event being selected from a predetermined event set based on the search query; the recommended contents being provided in a structured template including one or more elements; each element is associated with a feature of the event; each feature of the event corresponds to a search intent. Each element includes one or more sub-contents, and each sub-content is correlated to corresponding recommended contents.
    Type: Application
    Filed: November 30, 2016
    Publication date: February 20, 2020
    Inventors: Yumao Lu, Yongjian Deng, Linjun Shou, Wenbin Cai, Jun Pan, Jie Zhou, Baoquan Fan
  • Patent number: 10519163
    Abstract: This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: December 31, 2019
    Assignee: Incyte Corporation
    Inventors: Yun-Long Li, David M. Burns, Hao Feng, Joseph Glenn, Chunhong He, Song Mei, Jun Pan, Xiaozhao Wang, Yingda Ye
  • Publication number: 20190382380
    Abstract: Disclosed are compounds of Formula (I?) methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.
    Type: Application
    Filed: February 19, 2019
    Publication date: December 19, 2019
    Inventors: Oleg Vechorkin, Jun Pan, Alexander Sokolsky, Evan Styduhar, Qinda Ye, Wenqing Yao
  • Publication number: 20190359885
    Abstract: Embodiments of the present disclosure provide for methods of making quantum dots (QDs) (passivated or unpassivated) using a continuous flow process, systems for making QDs using a continuous flow process, and the like. In one or more embodiments, the QDs produced using embodiments of the present disclosure can be used in solar photovoltaic cells, bio-imaging, IR emitters, or LEDs.
    Type: Application
    Filed: June 10, 2019
    Publication date: November 28, 2019
    Inventors: Osman M. BAKR, Jun PAN, Ala'a EL-BALLOULI, Kristian Rahbek KNUDSEN, Ahmed L. ABDELHADY
  • Publication number: 20190343814
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.
    Type: Application
    Filed: July 22, 2019
    Publication date: November 14, 2019
    Inventors: Alexander Sokolsky, Oleg Vechorkin, Kai Liu, Jun Pan, Wenqing Yao, Qinda Ye
  • Publication number: 20190330527
    Abstract: Described herein are compositions and methods relating to light converting luminescent composite materials.
    Type: Application
    Filed: January 11, 2018
    Publication date: October 31, 2019
    Inventors: Makhsud SAIDAMINOV, Yuhai ZHANG, Jun PAN, Ibrahim DURSUN, Omar Mohammed ABDELSABOOR, Osman BAKR
  • Publication number: 20190315743
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.
    Type: Application
    Filed: June 27, 2019
    Publication date: October 17, 2019
    Inventors: Kai Liu, Jun Pan, Alexander Sokolsky, Oleg Vechorkin, Hai Fen Ye, Qinda Ye, Wenqing Yao
  • Publication number: 20190213153
    Abstract: In an embodiment, a processor for performance state adjustment includes a plurality of processing engines (PEs), a power control unit, and an input/output memory management unit (IOMMU). The IOMMU is to determine a destination PE for a user interrupt based on mapping data of the IOMMU, and to send a notification of the user interrupt to the power control unit. The notification indicates the destination PE for the user interrupt. The power control unit is to adjust a performance state of the destination PE in response to the notification of the user interrupt. Other embodiments are described and claimed.
    Type: Application
    Filed: January 8, 2018
    Publication date: July 11, 2019
    Inventors: Jacob Jun Pan, Ashok Raj, Srinivas Pandruvada
  • Publication number: 20190209537
    Abstract: The present disclosure describes thiazole and pyridine carboxamide derivatives, their compositions and methods of use. The compounds inhibit the activity of the Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.
    Type: Application
    Filed: March 11, 2019
    Publication date: July 11, 2019
    Inventors: Chu-Biao Xue, Yun-Long Li, Hao Feng, Jun Pan, Anlai Wang, Ke Zhang, Wenqing Yao, Fenglei Zhang, Jincong Zhuo
  • Patent number: 10310830
    Abstract: Systems, methods, and computer readable media to improve the development of image processing intensive programs are described. In general, techniques are disclosed to non-intrusively monitor the run-time performance of shader programs on a graphics processing unit (GPU)—that is, to profile shader program execution. More particularly, the shader profiling comprises of sampling data during the execution of a compiled code on GPU. The execution duration of the sequences of instructions within the code is determined. Subsequently, based relative latency of the instructions within the sequence, the duration time for each binary instruction is determined. The binary instructions are then mapped to source code in order to obtain the amount of time each source code instruction in a shader take to execute per draw call.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: June 4, 2019
    Assignee: Apple Inc.
    Inventors: Syed Irfan Zaidi, Sun Tjen Fam, Puyan Lotfi, Venkat R. Indukuru, Jun Pan, Andrew M. Sowerby, Jean-Luc Duprat
  • Patent number: 10301543
    Abstract: Embodiments of the present disclosure provide for methods of making quantum dots (QDs) (passivated or unpassivated) using a continuous flow process, systems for making QDs using a continuous flow process, and the like. In one or more embodiments, the QDs produced using embodiments of the present disclosure can be used in solar photovoltaic cells, bio-imaging, IR emitters, or LEDs.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: May 28, 2019
    Assignee: KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Osman M. Bakr, Jun Pan, Ala'a El-Ballouli, Kristian Rahbek Knudsen, Ahmed L. Abdelhady
  • Patent number: 10280164
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: May 7, 2019
    Assignee: Incyte Corporation
    Inventors: Qinda Ye, Kai Liu, Jun Pan, Alexander Sokolsky, Oleg Vechorkin, Wenqing Yao
  • Patent number: 10266530
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: April 23, 2019
    Assignee: Incyte Corporation
    Inventors: Oleg Vechorkin, Jun Pan, Kai Liu, Alexander Sokolsky, Anlai Wang, Hai Fen Ye, Wenqing Yao
  • Publication number: 20190106419
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.
    Type: Application
    Filed: December 4, 2018
    Publication date: April 11, 2019
    Inventors: Oleg Vechorkin, Jun Pan, Kai Liu, Alexander Sokolsky, Anlai Wang, Hai Fen Ye, Qinda Ye, Wenqing Yao